FIELD: medicine.
SUBSTANCE: method consists in cellular therapy. According to experimental investigation results the chosen portion of cells known for limb ischemia treatment shall be divided into two parts. One part of cells is intramuscularly injected and the other part is injected intraarterially.
EFFECT: ensuring optimal conditions for limb circulation management.
1 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DIFFUSE MYOCARDIAL DAMAGE | 2011 |
|
RU2464045C1 |
| METHOD OF TREATING LOWER EXTREMITY ISCHEMIA | 2012 |
|
RU2546007C2 |
| METHOD OF TREATMENT OF ISCHEMIC ANGIOPATHY OF LOWER EXTREMITY VESSELS | 2017 |
|
RU2649498C1 |
| METHOD FOR TREATMENT OF LOWER LIMBS ISCHEMIC DISEASES | 2015 |
|
RU2633487C2 |
| METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2735838C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC LOWER EXTREMITY ISCHEMIA CASES | 2005 |
|
RU2286159C1 |
| METHOD OF COMBINED SURGICAL STIMULATION OF LOWER EXTREMITY CHRONIC LOWER LIMB NEOANGIOGENESIS | 2018 |
|
RU2703395C1 |
| BIOENGINEERING METHOD FOR BRAIN FUNCTIONS REPAIR | 1998 |
|
RU2152038C1 |
| METHOD FOR STIMULATING ANGIOGENESIS USING GENETICALLY MODIFIED UMBILICAL CORD BLOOD CELLS | 2017 |
|
RU2663470C2 |
| METHOD OF TREATING CHRONIC LIMB ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2556606C1 |
